COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 159 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,300 | -75.6% | 2,698 | -76.5% | 0.00% | – |
| Q2 2023 | $247,049 | +5.0% | 11,496 | +17.2% | 0.00% | – |
| Q1 2023 | $235,366 | +408.5% | 9,811 | +391.8% | 0.00% | – |
| Q4 2022 | $46,284 | -18.8% | 1,995 | -43.9% | 0.00% | – |
| Q3 2022 | $57,000 | +256.2% | 3,556 | +300.0% | 0.00% | – |
| Q2 2022 | $16,000 | -56.8% | 889 | -51.7% | 0.00% | – |
| Q1 2022 | $37,000 | -36.2% | 1,839 | -40.7% | 0.00% | – |
| Q4 2021 | $58,000 | -26.6% | 3,102 | -23.3% | 0.00% | – |
| Q3 2021 | $79,000 | -79.0% | 4,045 | -74.5% | 0.00% | – |
| Q2 2021 | $376,000 | -17.9% | 15,891 | -17.7% | 0.00% | – |
| Q1 2021 | $458,000 | +48.7% | 19,312 | +25.8% | 0.00% | – |
| Q4 2020 | $308,000 | +202.0% | 15,351 | +215.7% | 0.00% | – |
| Q3 2020 | $102,000 | -69.5% | 4,862 | -74.5% | 0.00% | – |
| Q2 2020 | $334,000 | -10.2% | 19,084 | -16.1% | 0.00% | – |
| Q1 2020 | $372,000 | -64.0% | 22,739 | -54.8% | 0.00% | – |
| Q4 2019 | $1,034,000 | +205.9% | 50,261 | +70.7% | 0.00% | – |
| Q3 2019 | $338,000 | +838.9% | 29,450 | +963.2% | 0.00% | – |
| Q2 2019 | $36,000 | -48.6% | 2,770 | -40.0% | 0.00% | – |
| Q1 2019 | $70,000 | -50.4% | 4,620 | -43.9% | 0.00% | – |
| Q4 2018 | $141,000 | +13.7% | 8,239 | -2.5% | 0.00% | – |
| Q3 2018 | $124,000 | -92.5% | 8,454 | -87.8% | 0.00% | -100.0% |
| Q2 2018 | $1,646,000 | -68.1% | 69,018 | -65.8% | 0.00% | -50.0% |
| Q1 2018 | $5,160,000 | +85.4% | 201,958 | +34.0% | 0.00% | +100.0% |
| Q4 2017 | $2,783,000 | +2341.2% | 150,754 | +1279.3% | 0.00% | – |
| Q3 2017 | $114,000 | -57.3% | 10,930 | -48.7% | 0.00% | – |
| Q2 2017 | $267,000 | +92.1% | 21,304 | +54.7% | 0.00% | – |
| Q1 2017 | $139,000 | +148.2% | 13,767 | +283.2% | 0.00% | – |
| Q4 2016 | $56,000 | -15.2% | 3,593 | +5.1% | 0.00% | – |
| Q3 2016 | $66,000 | +83.3% | 3,418 | +13.9% | 0.00% | – |
| Q2 2016 | $36,000 | -56.1% | 3,000 | -33.3% | 0.00% | – |
| Q1 2016 | $82,000 | +30.2% | 4,500 | +96.3% | 0.00% | – |
| Q4 2015 | $63,000 | +472.7% | 2,292 | +358.4% | 0.00% | – |
| Q3 2015 | $11,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |